![Micro Total Analysis Systems: Fundamental Advances and Applications in the Laboratory, Clinic, and Field | Analytical Chemistry Micro Total Analysis Systems: Fundamental Advances and Applications in the Laboratory, Clinic, and Field | Analytical Chemistry](https://pubs.acs.org/cms/10.1021/ac3031543/asset/images/large/ac-2012-031543_0002.jpeg)
Micro Total Analysis Systems: Fundamental Advances and Applications in the Laboratory, Clinic, and Field | Analytical Chemistry
![Enzyme-free targeted DNA demethylation using CRISPR–dCas9-based steric hindrance to identify DNA methylation marks causal to altered gene expression | Nature Protocols Enzyme-free targeted DNA demethylation using CRISPR–dCas9-based steric hindrance to identify DNA methylation marks causal to altered gene expression | Nature Protocols](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41596-022-00741-3/MediaObjects/41596_2022_741_Fig1_HTML.png)
Enzyme-free targeted DNA demethylation using CRISPR–dCas9-based steric hindrance to identify DNA methylation marks causal to altered gene expression | Nature Protocols
![2-Mercapto-Quinazolinones as Inhibitors of Type II NADH Dehydrogenase and Mycobacterium tuberculosis: Structure–Activity Relationships, Mechanism of Action and Absorption, Distribution, Metabolism, and Excretion Characterization | ACS Infectious Diseases 2-Mercapto-Quinazolinones as Inhibitors of Type II NADH Dehydrogenase and Mycobacterium tuberculosis: Structure–Activity Relationships, Mechanism of Action and Absorption, Distribution, Metabolism, and Excretion Characterization | ACS Infectious Diseases](https://pubs.acs.org/cms/10.1021/acsinfecdis.7b00275/asset/images/large/id-2017-002759_0014.jpeg)
2-Mercapto-Quinazolinones as Inhibitors of Type II NADH Dehydrogenase and Mycobacterium tuberculosis: Structure–Activity Relationships, Mechanism of Action and Absorption, Distribution, Metabolism, and Excretion Characterization | ACS Infectious Diseases
![dCas9-VPR-mediated transcriptional activation of functionally equivalent genes for gene therapy | Nature Protocols dCas9-VPR-mediated transcriptional activation of functionally equivalent genes for gene therapy | Nature Protocols](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41596-021-00666-3/MediaObjects/41596_2021_666_Fig1_HTML.png)
dCas9-VPR-mediated transcriptional activation of functionally equivalent genes for gene therapy | Nature Protocols
![2-Azabicyclo[2.2.1]hept-5-en-3-one: Chemical Profile of a Versatile Synthetic Building Block and its Impact on the Development of Therapeutics | Chemical Reviews 2-Azabicyclo[2.2.1]hept-5-en-3-one: Chemical Profile of a Versatile Synthetic Building Block and its Impact on the Development of Therapeutics | Chemical Reviews](https://pubs.acs.org/cms/10.1021/cr2004822/asset/images/large/cr-2011-004822_0057.jpeg)
2-Azabicyclo[2.2.1]hept-5-en-3-one: Chemical Profile of a Versatile Synthetic Building Block and its Impact on the Development of Therapeutics | Chemical Reviews
GPIIb/IIIa Receptor Targeted Rutin Loaded Liposomes for Site-Specific Antithrombotic Effect | Molecular Pharmaceutics
![Programmable receptors enable bacterial biosensors to detect pathological biomarkers in clinical samples | Nature Communications Programmable receptors enable bacterial biosensors to detect pathological biomarkers in clinical samples | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-25538-y/MediaObjects/41467_2021_25538_Fig1_HTML.png)